...
首页> 外文期刊>Vaccine >Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life
【24h】

Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life

机译:无细胞百日咳疫苗接种后的长期体液免疫和细胞介导的免疫优于生命第二年加强疫苗接种后6年的全细胞疫苗

获取原文
获取原文并翻译 | 示例
           

摘要

Humoral and cell-mediated immune responses (CMI) were evaluated in subjects 3 and 6 years after primary and booster vaccination with either three-component acellular (Pa) or whole-cell (Pw) vaccines. Low anti-pertussis toxin (PT) antibody levels confirmed the absence of pertussis disease, consistent with ongoing protection. Anti-pertactin (PRN) antibodies, remained at higher levels in Pa-vaccinated subjects. At year 6, CMI responses continued to be present and were higher in Pa-vaccinated than Pw-vaccinated subjects. Long-term protection with Pa vaccines can be expected to be at least as good as that provided by efficacious Pw vaccines.
机译:在接种三组分无细胞疫苗或全细胞疫苗后的3年和6年,对受试者的体液和细胞介导的免疫反应(CMI)进行了评估。抗百日咳毒素(PT)抗体水平低证实没有百日咳疾病,与持续的保护措施一致。抗泛素(PRN)抗体在Pa疫苗接种的受试者中保持较高水平。在第6年,CMI应答继续存在,接受Pa疫苗接种的受试者比接受Pw疫苗接种的受试者更高。预计Pa疫苗的长期保护至少与有效Pw疫苗所提供的保护一样好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号